How to Avoid Local Side Effects of Bladder Photodynamic Therapy: Impact of the Fluence Rate
Authors:
- 1 August 2013
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 190 (2) , 731-736
Abstract
We studied how to avoid irritative bladder symptoms after bladder photodynamic therapy, such as urgency, frequency and pain, which are associated with the inflammation and destruction of normal urothelium. Rats bearing orthotopic bladder tumors were instilled with hexyl-aminolevulinate and illuminated with red light at a high vs low (100 vs 15 mW/cm(2)) fluence rate. Cystectomy specimens 48 hours after treatment were subjected to anatomopathological examination. Inflammatory reaction and apoptosis were evaluated. In vivo photobleaching was assessed during illumination at each fluence rate. All superficial tumors were eradicated irrespective of light dose and fluence rate. High fluence rates induced necrosis with inflammatory reaction and absent normal urothelium. Low fluence rates did not provoke inflammation and resulted in apoptotic cell death with preserved urothelial integrity. This could be attributable to faster photobleaching of the photosensitizer in normal urothelium at low fluence rates. Bladder photodynamic therapy at a low fluence rate minimizes side effects without hampering therapeutic efficacy.Keywords
This publication has 22 references indexed in Scilit:
- New Optical Imaging Technologies for Bladder Cancer: Considerations and PerspectivesJournal of Urology, 2012
- Fractionated Illumination Significantly Improves the Response of Superficial Basal Cell Carcinoma to Aminolevulinic Acid Photodynamic TherapyJournal of Investigative Dermatology, 2006
- Hexyl-aminolevulinate-mediated photodynamic therapy: How to spare normal urothelium. An in vitro approachLasers in Surgery and Medicine, 2006
- Photodynamic Applications in Superficial Bladder Cancer: Facts and Hopes!Journal of Environmental Pathology, Toxicology and Oncology, 2006
- A phase‐1 study of sequential mitomycin C and 5–aminolaevulinic acid‐mediated photodynamic therapy in recurrent superficial bladder carcinomaBJU International, 2005
- Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcomeBritish Journal of Dermatology, 2004
- Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center studyUrology, 2003
- Whole bladder photodynamic therapy with 5-aminolevulinic acid using a white light sourceUrology, 2003
- Photodynamic therapy for superficial bladder cancer under local anaestheticBJU International, 2002
- Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladderUrology, 1995